Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Business
  • Published:

Drive for drugs leads to baby clinical trials

US regulators are moving sharply to ease the early stages of drug development, despite safety concerns. Meredith Wadman reports.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Related links

Related links

Related links in Nature Research

London's disastrous drug trial has serious side effects for research

Earlier drug tests on people could be unsafe, critics warn

Related external links

UAB Gene therapy

FDA exploratory IND guidance

FDA GMP guidance

Rights and permissions

Reprints and permissions

About this article

Cite this article

Drive for drugs leads to baby clinical trials. Nature 440, 406–407 (2006). https://doi.org/10.1038/440406a

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/440406a

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing